International Society for the Study of Women's Sexual Health

In Memoriam - Fernand Labrie, MD, PhD (1937-2019)

The field of women’s sexual health has lost another crusader.  Fernand Labrie, born in Laurierville, Quebec on June 28, 1937 and one of the greatest scientists in Canada’s history, died on Wednesday of an infection at age 81. 
 
Fernand received his medical degree from Laval University in 1962. While many sexual medical specialists know him as the founder of Endoceutics and inventor of Intrarosa, he established the first molecular endocrinology laboratory in the world at Laval University Quebec Canada. He studied prostate cancer before turning his interest to androgens and estrogens in menopause.  
 
Fernand was a very special dynamic and hard-working researcher. Over the course of his lifetime he published more than 1240 peer review articles and was cited more than 50,000 times, making him the most cited Canadian researcher in the world, in all areas of research combined. This includes several publications in the Journal of Sexual Medicine regarding his invention Intravaginal prasterone.
 
As his passion was women's sexual health, Fernand was an ardent supporter of ISSWSH. He lectured at ISSWSH, back in its infancy in 1998, while he was still a researcher at Laval University. He subsequently lectured at ISSWSH, primarily on intracrinology, and just last year attended the ISSWSH Annual Meeting in San Diego, CA. His research will benefit many of our patients and change the way we look at hormones for years to come.

Save the Date

ISSWSH Fall Course 2019
November 14-16, 2019   141 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH Annual Meeting 2020
March 5-8, 2020   253 days left
Renaissance Orlando at Seaworld, Orlando, FL, USA

ISSWSH Annual Meeting 2021
March 4-7, 2021   617 days left
Renaissance Dallas Hotel, Dallas, TX, USA

Latest Tweets

FDA slow to implement regulations on Vaginal Mesh, increasing public apprehension in use of devices for health bene… https://t.co/uAgdBlNDS1 ISSWSH
FDA approves new treatment for hypoactive sexual desire disorder in premenopausal women https://t.co/1iBr8jmmOE ISSWSH
“I realize that there are a lot of critics,” she said in 1983, “but I’ve found out that nine times out of 10 they h… https://t.co/oAPG388zrw ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!